EDAP TMS, a leading medical device company, has reported record-breaking results for its fourth quarter and full year 2025 ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. EDAP TMS ( (EDAP)) has shared an update.

EDAP Q4 2025 earnings call highlights: record Focal One HIFU growth, FDA clearance, reimbursement boosts and 2026 guidance.

EDAP TMS S.A. shares have pushed lower in H2 FY'23, presenting an opportunity to add on weakness. EDAP's Q1 revenues were up 13.8% YoY, with HIFU sales up around 40% YoY. On examination, sentiment and ...

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates ...